Study of the Efficacy and Success Rate of Single Dose Oral Mifepristone and Vaginal Misoprostol v/s Vaginal Misoprostol alone for Second Trimester Termination of Pregnancy


Affiliations

  • Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Department of Obstetrics and Gynaecology, Nashik, Maharashtra, 422003, India

Abstract

Background: Second trimester abortions constitute 10-15% of all induced abortions and are considered to be less safe than first trimester abortions. The combination of mifepristone and misoprostol is now an established and highly effective method for second trimester abortion. Aim: To compare the efficacy and the success rate of single dose oral mifepristone plus vaginal misoprostol versus vaginal misoprostol alone for second trimester termination of pregnancy. Materials and Methods: A comparative study and was conducted in the Department of Obstetrics and Gynecology in a Tertiary Health Care Hospital. The study was carried out by dividing women into two groups (72 each). Group A received 200mg of oral Tablet Mifepristone and 400 of vaginal misoprostol (48 hours later) which was repeated every 4 hourly by 200 of vaginal misoprostol up to a maximum of 4 doses. Group B received 400 of vaginal misoprostol directly and the dose was repeated every 4 hourly by 200 of vaginal misoprostol up to a maximum of 4 doses. Results: The success rate in Group A was 98.6%, whereas in Group B was 84.7%. The mean induction abortion interval in Group A was lesser (6.2 hours) as compared to Group B (10.8 hours) (p value <0.00001). The mean dose of misoprostol in Group A was 613.88mcg compared to the Group B 1591.66mcg (p value <0.00001). Conclusion: Pretreatment with mifepristone significantly reduces the induction abortion interval (I-A-I) and the misoprostol dose.

Keywords

Induction Abortion Interval I-A-I, Mifepristone, Misoprostol, Second Trimester, Termination

Subject Discipline

Obstetrics and Gynaecology

Full Text:

References

Lalitkumar S, Bygdeman M, Gemzell-Danielsson K. Mid-trimester induced abortion: A review. Human Reproduction Update. 2007; 13(1):37–52. https://doi.org/10.1093/humupd/dml049 PMid:17050523

«India» UN. Available from http://www.un.org/esa/ population/publications/abortion/doc/india.doc

Akkenapally PL. A comparative study of misoprostol only and mifepristone plus misoprostol in second trimester termination of pregnancy. The Journal of Obstetrics and Gynecology of India. 2016; 66(S1):S251–7. DOI: 10.1007/ s13224-016-0869-z. https://doi.org/10.1007/s13224-0160869-z

Tripti N, Namrata S. Misoprostol Vs mifepristone and misoprostol in second trimester termination of pregnancy. The Journal of Obstetrics and Gynecology of India. 2011; 61(6):659–662. DOI: 10.1007/s13224-011-0118-4. https:// doi.org/10.1007/s13224-011-0118-4

Ashok PW, Templeton A. Nonsurgical mid-trimester termination of pregnancy: A review of 500 consecutive cases. British Journal of Obstetrics and Gynecology. 1999 Jul, 106:706–10. https://doi.org/10.1111/j.1471-0528.1999.tb08371.x PMid:10428528

Modak R, Biswas DK, Ghost A, et al. Comparative study of sublingual and vaginal misoprostol in second trimester induced abortion. Open J Obstet Gynaecol. 2014; 4:751–6. https://doi.org/10.4236/ojog.2014.413104

Ngoc NT, Scochet T, Raghavan S, et al. Mifepristone and misoprostol compared with misoprostol alone for second trimester abortion: A randomized controlled trial. Obstet Gynaecol. 2011; 118(3):601–8 https://doi.org/10.1097/AOG.0b013e318227214e PMid:21860289

Dabash R, Chelli H, Hajri S, et al. A double blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy. Int J Gynaecol Obstet. 2015; 130(1):40–4. https://doi.org/10.1016/j.ijgo.2015.02.023 PMid:25896965

Kranti KK. Pre-induction with mifepristone for second trimester termination of pregnancy. The Journal of Obstetrics and Gynecology of India. 2014; 64(2):102–4. DOI 10.1007/s13224-013-0472-5. https://doi.org/10.1007/s13224-013-0472-5

Ashok PW, Templeton A. Nonsurgical mid-trimester termination of pregnancy: A review of 500 consecutive cases. British Journal of Obstetrics and Gynecology. 1999; 106(7):706–10. https://doi.org/10.1111/j.1471-0528.1999.tb08371.x

Wong KS, Ngai CS, Yeo EL, et al. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: A randomized comparative trial. Human Reproduction. 2000; 15(3):709–12. https://doi.org/10.1093/humrep/15.3.709 PMid:10686224


Refbacks

  • There are currently no refbacks.